Bonomini A, Mercorelli B, Loregian A
Cell Mol Life Sci. 2025; 82(1):75.
PMID: 39945883
PMC: 11825441.
DOI: 10.1007/s00018-025-05611-1.
Bai Y, Liu T, Zhang S, Shi Y, Yang Y, Ding M
Int J Biol Sci. 2025; 21(3):989-1013.
PMID: 39897040
PMC: 11781171.
DOI: 10.7150/ijbs.105086.
Cheng P, Wang X, Wang S, Ren S, Liang Z, Guo K
J Virol. 2025; 99(2):e0182724.
PMID: 39840984
PMC: 11852836.
DOI: 10.1128/jvi.01827-24.
Kamio N, Cueno M, Takagi A, Imai K
J Biol Chem. 2025; 301(2):108166.
PMID: 39793895
PMC: 11834065.
DOI: 10.1016/j.jbc.2025.108166.
Saha P, Saha R, Datta Chaudhuri R, Sarkar R, Sarkar M, Koley H
Viruses. 2024; 16(8).
PMID: 39205291
PMC: 11359333.
DOI: 10.3390/v16081317.
Proteomics Analysis of Duck Lung Tissues in Response to Highly Pathogenic Avian Influenza Virus.
Vijayakumar P, Mishra A, Deka R, Pinto S, Subbannayya Y, Sood R
Microorganisms. 2024; 12(7).
PMID: 39065055
PMC: 11278641.
DOI: 10.3390/microorganisms12071288.
Repurposing Anticancer Drugs Targeting the MAPK/ERK Signaling Pathway for the Treatment of Respiratory Virus Infections.
Liu Y, Luo Z
Int J Mol Sci. 2024; 25(13).
PMID: 39000055
PMC: 11240997.
DOI: 10.3390/ijms25136946.
Activation of the MAPK network provides a survival advantage during the course of COVID-19-induced sepsis: a real-world evidence analysis of a multicenter COVID-19 Sepsis Cohort.
Witowski A, Palmowski L, Rahmel T, Nowak H, Ehrentraut S, Putensen C
Infection. 2024; 53(1):107-115.
PMID: 38896372
PMC: 11825614.
DOI: 10.1007/s15010-024-02325-7.
H9N2 Avian Influenza Virus Downregulates FcRY Expression in Chicken Macrophage Cell Line HD11 by Activating the JNK MAPK Pathway.
Sun Z, Zhang W, Li J, Yang K, Zhang Y, Li Z
Int J Mol Sci. 2024; 25(5).
PMID: 38473897
PMC: 10932074.
DOI: 10.3390/ijms25052650.
Unveiling the role of host kinases at different steps of influenza A virus life cycle.
Dey S, Mondal A
J Virol. 2024; 98(1):e0119223.
PMID: 38174932
PMC: 10805039.
DOI: 10.1128/jvi.01192-23.
Efficacy and safety of zapnometinib in hospitalised adult patients with COVID-19 (RESPIRE): a randomised, double-blind, placebo-controlled, multicentre, proof-of-concept, phase 2 trial.
Rohde G, Stenglein S, Prozesky H, Manudhane G, Sandulescu O, Bauer M
EClinicalMedicine. 2023; 65:102237.
PMID: 38106555
PMC: 10725048.
DOI: 10.1016/j.eclinm.2023.102237.
Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer.
Meissner R, Wixler V, Wulfert F, Jacob J, Hale B, Robeck T
Mol Ther Oncolytics. 2023; 31:100741.
PMID: 38020062
PMC: 10679949.
DOI: 10.1016/j.omto.2023.100741.
MicroRNA expression profiling in the lungs of genetically different Ri chicken lines against the highly pathogenic avian influenza H5N1 virus.
Lee S, Kang S, Heo J, Hong Y, Vu T, Truong A
J Anim Sci Technol. 2023; 65(4):838-855.
PMID: 37970505
PMC: 10640957.
DOI: 10.5187/jast.2022.e127.
Influenza A virus replication has a stronger dependency on Raf/MEK/ERK signaling pathway activity than SARS-CoV-2.
Hoffmann H, Ebensperger M, Schonsiegel A, Hamza H, Koch-Heier J, Schreiber A
Front Cell Infect Microbiol. 2023; 13:1264983.
PMID: 37965261
PMC: 10641236.
DOI: 10.3389/fcimb.2023.1264983.
MAFB shapes human monocyte-derived macrophage response to SARS-CoV-2 and controls severe COVID-19 biomarker expression.
Simon-Fuentes M, Rios I, Herrero C, Lasala F, Labiod N, Luczkowiak J
JCI Insight. 2023; 8(24).
PMID: 37917179
PMC: 10807725.
DOI: 10.1172/jci.insight.172862.
Carbon dioxide and MAPK signalling: towards therapy for inflammation.
Galganska H, Jarmuszkiewicz W, Galganski L
Cell Commun Signal. 2023; 21(1):280.
PMID: 37817178
PMC: 10566067.
DOI: 10.1186/s12964-023-01306-x.
Pathogenicity and virulence of influenza.
Liang Y
Virulence. 2023; 14(1):2223057.
PMID: 37339323
PMC: 10283447.
DOI: 10.1080/21505594.2023.2223057.
The Immunosuppressive Roles of PD-L1 during Influenza A Virus Infection.
Ning H, Chiu S, Xu X, Ma Y, Chen J, Yang G
Int J Mol Sci. 2023; 24(10).
PMID: 37239931
PMC: 10218452.
DOI: 10.3390/ijms24108586.
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2.
Xue Y, Mei H, Chen Y, Griffin J, Liu Q, Weisberg E
MedComm (2020). 2023; 4(3):e254.
PMID: 37193304
PMC: 10183156.
DOI: 10.1002/mco2.254.
The Modulation of Immune Responses in -Infected Fish Cells through MAPK/ERK Signalling.
Lertwanakarn T, Khemthong M, Tattiyapong P, Surachetpong W
Viruses. 2023; 15(4).
PMID: 37112880
PMC: 10144228.
DOI: 10.3390/v15040900.